Smart Choices Program suspends operations
This article was originally published in The Tan Sheet
Packaged-foods marketers including Kraft Foods, General Mills, Kellogg and Unilever will phase out the Smart Choices label, which FDA Commissioner Margaret Hamburg, legislators and litigators recently complained misleads consumers to believe unhealthy foods are nutritious. The Smart Choices Program postponed operation Oct. 23 and Smart Choices Chair Mike Hughes said in a release the program welcomes FDA's interest in developing standard front-of-label and shelf-label criteria, as indicated by Hamburg (1"The Tan Sheet" Oct. 26, 2009). Hughes added the program will work with Connecticut Attorney General Richard Blumenthal, who is investigating the program because it deems "mayonnaise, sugar-laden cereals and other nutritiously suspect foods 'Smart Choices.'
You may also be interested in...
A spate of FDA warning letters detailing labeling violations and an open letter from Commissioner Margaret Hamburg largely quash any hopes the food industry might have had for regulatory latitude to make aggressive health claims
Commissioner Margaret Hamburg announces plans to impose a regulation for nutritional criteria for front-of-package labeling. In light of concerns about industry-sponsored Smart Choices and similar programs, Hamburg said FDA will examine existing FOP and shelf labels for foods to ensure they are not false or misleading under existing law (1"The Tan Sheet" Sept. 28, 2009). During an Oct. 20 media call, Hamburg said nutritionists question whether industry's FOP labels are "more marketing information than nutrition information. Judging from some of the labels we have seen, we think this a valid concern." She cited the system adopted in the U.K., in which the government set labeling standards and retailers used them to implement a system. FDA expects to "see significant progress toward our goal" of publishing the regulation by the end of 2010, the commissioner added
Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.